Lack of medical investment, healthcare infra big challenges for India’s COVID-19 fight: Fitch

By: |
Published: May 14, 2020 10:57:59 AM

With 8.5 hospital beds per 10,000 citizens and eight physicians per 10,000, the country's healthcare sector is not equipped for such a crisis.

medical investment, healthcare infra, COVID-19 pandemic, fitch solutions, latest news on coronavirus pandemicWith 8.5 hospital beds per 10,000 citizens and eight physicians per 10,000, the country’s healthcare sector is not equipped for such a crisis.

Despite additional funding, the continued lack of medical investment and healthcare infrastructure will present challenges to mounting an effective response in India against COVID-19 pandemic, Fitch Solutions has said.

“The continued lack of medical funding and healthcare infrastructure inform our view for the potential epidemic to be worse in India if it is not adequately contained,” Fitch Solutions Country Risk and Industry Research (a unit of Fitch Group) said in its outlook for India’s pharmaceutical market.

With 8.5 hospital beds per 10,000 citizens and eight physicians per 10,000, the country’s healthcare sector is not equipped for such a crisis.

Also read| Check Coronavirus latest updates here:

Moreover, the significant inefficiency, dysfunctioning and acute shortage of the healthcare delivery systems in the public sector do not match up with the growing needs of the population.

In addition, more than 80 per cent of the population still does not have any significant health insurance coverage, and approximately 68 per cent of the Indians have limited or no access to essential medicines.

Furthermore, over the last two decades, the availability of free medicines in public healthcare facilities has declined from 31.2 per cent to 8.9 per cent for inpatient care, and from 17.8 per cent to 5.9 per cent for outpatient care, the rating agency said citing a Public Health Foundation of India study.

It also said that the growth within India’s pharmaceuticals and healthcare market will be supported by the government’s push towards achieving universal health coverage status.

An improving business environment and planned healthcare reforms will be positive for innovative drugmakers and as such the market will continue to hold significant potential as the third-largest pharmaceutical market in the Asia-Pacific region, it said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Coronavirus in Assam: 123 more test positive; total count reached 1,339
2Coronavirus Live Updates: India moves to 7th spot among top 10 worst-affected nations in the world
3Covid outbreak: Rural India gets infected, green areas turn red